Diabetic retinopathy GWAS: African Americans

Dataset

Download summary statistics | README

Publications

Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control.
Pollack S, et al.
Diabetes. 2019 Feb; 68(2): 441–456. doi: 10.2337/db18-0567
PMID:30487263

Dataset phenotypes

  • Diabetic retinopathy (DR) vs no DR
  • Diabetic retinopathy (DR) vs no DR acct DoD-GC (accounting for duration of diabetes and glycemic control)
  • Proliferative diabetic retinopathy (PDR) vs no PDR
  • Proliferative diabetic retinopathy (PDR) vs no PDR acct DoD-GC (accounting for duration of diabetes and glycemic control)
  • Non-proliferative diabetic retinopathy vs no DR
  • Non-proliferative diabetic retinopathy vs no DR acct DoD-GC (accounting for duration of diabetes and glycemic control)
  • Proliferative diabetic retinopathy vs no DR
  • Proliferative diabetic retinopathy vs no DR acct DoD-GC (accounting for duration of diabetes and glycemic control)

Dataset subjects (primary "any DR" analysis)

Cases Controls Cohort(Click to view selection criteria for cases and controls) Ancestry
274 56 African American Proliferative Diabetic Retinopathy Study (AAPDR) African American
96 265 Atherosclerosis Risk in Communities Study (ARIC) African American
19 35 Cardiovascular Health Study (CHS) African American
330 167 Family Study of Nephropathy and Diabetes-Eye (FIND-Eye) African American
91 160 Jackson Heart Study (JHS) African American
101 258 Multiethnic Study of Atherosclerosis (MESA) African American

 

Experiment summary

This study analyzed genetic associations in type 2 diabetics for four diabetic retinopathy (DR) case-control definitions. Two datasets are incorporated into the Knowledge Portal: one for subjects of African American ancestry and one for subjects of European ancestry. The primary case-control definition compared any DR to no DR using the Early Treatment Diabetic Retinopathy Study (ETDRS) score thresholds ETDRS ≥ 14 for cases and ETDRS < 14 for controls. Secondary analyses compared:

  • patients with proliferative diabetic retinopathy (PDR) to those without PDR (ETDRS ≥ 60 vs. ETDRS < 60)
  • patients with nonproliferative DR (NPDR) or worse to those without DR (ETDRS ≥ 30 vs. ETDRS < 14)
  • patients with PDR to those without DR (ETDRS ≥ 60 vs. ETDRS < 14)

Analyses were performed with or without liability threshold modeling to account for the strongest two covariates, duration of diabetes and glycemic control.

Dataset ID
GWAS_DiabeticRetino_aa